Abingworth as of Dec. 31, 2010
Portfolio Holdings for Abingworth
Abingworth holds 28 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 51.8 | $139M | 17M | 8.20 | |
| Alnylam Pharmaceuticals (ALNY) | 6.9 | $19M | 1.9M | 9.86 | |
| Micromet | 5.5 | $15M | 1.8M | 8.11 | |
| Incyte Corporation (INCY) | 5.1 | $14M | 830k | 16.55 | |
| Caliper Life Sciences | 5.0 | $13M | 2.1M | 6.34 | |
| Zogenix | 4.5 | $12M | 2.3M | 5.19 | |
| Nektar Therapeutics (NKTR) | 3.4 | $9.2M | 719k | 12.85 | |
| OncoGenex Pharmaceuticals | 3.0 | $8.0M | 479k | 16.65 | |
| Celgene Corporation | 2.0 | $5.4M | 91k | 59.10 | |
| NPS Pharmaceuticals | 1.8 | $4.8M | 613k | 7.89 | |
| Novavax | 1.6 | $4.4M | 1.8M | 2.42 | |
| Alexza Pharmaceuticals | 1.3 | $3.6M | 2.9M | 1.25 | |
| Exelixis (EXEL) | 1.3 | $3.4M | 415k | 8.20 | |
| Cardiome Pharma Corp | 1.1 | $3.1M | 481k | 6.40 | |
| ISIS Pharmaceuticals | 1.0 | $2.7M | 268k | 10.12 | |
| InterMune | 0.7 | $2.0M | 55k | 36.40 | |
| Medicines Company | 0.6 | $1.5M | 107k | 14.13 | |
| Celldex Therapeutics | 0.5 | $1.4M | 343k | 4.12 | |
| Zalicus | 0.5 | $1.4M | 864k | 1.58 | |
| Isis Pharmaceuticals Inc Del note 2.625% 2/1 | 0.5 | $1.3M | 1.3k | 1000.00 | |
| Affymetrix | 0.5 | $1.2M | 246k | 5.03 | |
| Allos Therapeutics | 0.5 | $1.2M | 265k | 4.59 | |
| Trimeris | 0.3 | $787k | 320k | 2.46 | |
| Cornerstone Therapeutics | 0.2 | $488k | 85k | 5.76 | |
| AVANIR Pharmaceuticals | 0.2 | $457k | 113k | 4.06 | |
| Sunesis Pharmaceuticals | 0.1 | $388k | 776k | 0.50 | |
| EntreMed | 0.1 | $359k | 71k | 5.07 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $97k | 182k | 0.53 |
